| BC | breast cancer |
| CXCR4 | C-X-C chemokine receptor type 4 |
| DFS | disease-free survival |
| E1 | oestrone |
| E1S | oestrone sulphate |
| E2 | oestradiol |
| EPC-1 | early population doubling level cDNA-1 |
| ER | oestrogen receptor |
| FAK | focal adhesion kinase |
| HER2 | human epidermal growth factor receptor-2 |
| MT1-MMP | membrane-type 1 matrix metalloproteinase |
| NFκB | nuclear factor kappa B |
| OATP | organic anion transport protein |
| PEDF | pigment epithelium-derived factor |
| p-NFκB-p65 | phosphorylated-nuclear factor kappa B-p65 subunit |
| RANKL | receptor activator of nuclear factor kappa-Β ligand |
| RHOA | ras homolog family member A |
| RT | room temperature |
| SERPINF1 | serpin family F member 1 |
| STS | steroid sulfatase |
| TME | tumour microenvironment |
| TNBC | triple negative BC |
| TNF-α | tumour necrosis factor-alpha |
| uPA | urokinase-type plasminogen activator |
| uPAR | urokinase-type plasminogen activator receptor |
| VEGF | vascular endothelial growth factor |